Cabot (NYSE:CBT) PT Set at $82.00 by UBS Group

Cabot (NYSE:CBT) has been assigned a $82.00 target price by UBS Group in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage presently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective indicates a potential upside of 2.41% from the company’s previous close.

Separately, Wall Street Zen lowered Cabot from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th.

Cabot Trading Up 8.6%

CBT opened at $80.07 on Tuesday. The firm has a market cap of $4.30 billion, a P/E ratio of 10.47 and a beta of 0.87. Cabot has a 12 month low of $70.40 and a 12 month high of $117.46. The company has a current ratio of 1.96, a quick ratio of 1.30 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average of $75.80 and a 200 day moving average of $79.73.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. The company had revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 26.17% and a net margin of 11.14%. As a group, research analysts forecast that Cabot will post 7.57 EPS for the current year.

Institutional Trading of Cabot

Several institutional investors have recently added to or reduced their stakes in the company. American Century Companies Inc. lifted its stake in Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after purchasing an additional 174,921 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Cabot by 8.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company’s stock valued at $118,606,000 after acquiring an additional 108,397 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Cabot by 1.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,190,886 shares of the specialty chemicals company’s stock valued at $99,010,000 after acquiring an additional 19,333 shares in the last quarter. Invesco Ltd. raised its stake in shares of Cabot by 7.1% during the fourth quarter. Invesco Ltd. now owns 845,261 shares of the specialty chemicals company’s stock valued at $77,181,000 after acquiring an additional 55,905 shares in the last quarter. Finally, Copeland Capital Management LLC raised its stake in shares of Cabot by 5.8% during the first quarter. Copeland Capital Management LLC now owns 805,504 shares of the specialty chemicals company’s stock valued at $66,970,000 after acquiring an additional 44,132 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.